ACADIA PHARMACEUTICALS INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
ACAD$18.28+10.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss)
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net income (loss) | $226,451 | $(61,286) | $(215,975) |
| Other comprehensive income (loss): | |||
| Unrealized gain/(loss) on investment securities | 362 | 1,017 | (789) |
| Foreign currency translation adjustments | (94) | (18) | 6 |
| Comprehensive income (loss) | $226,719 | $(60,287) | $(216,758) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.